Published on in Vol 9 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/46051, first published
.
Journals
- Dong Y, Fan B, Li M, Zhang J, Xie S, Di S, Jia Q, Gong T. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma. Pathology - Research and Practice 2024;253:154964 View
- Li W, Wang Y, Li X, Wu H, Jia L. Dexmedetomidine hydrochloride plus sufentanil citrate inhibits glucose metabolism and epithelial‑mesenchymal transition in human esophageal squamous carcinoma KYSE30 cells by modulating the JAK/STAT3/HIF‑1α axis. Oncology Letters 2024;27(6) View